文献速递认知障碍与痴呆

阿尔茨海默病中病感失认的演变及其与淀粉样蛋白的关系

Evolution of anosognosia in alzheimer's disease and its relationship to amyloid.
PubMed 文献 · Ann Neurol · 2019-12-05

本研究在1070例阿尔茨海默病谱系人群中纵向评估记忆觉察(平均随访4.3次),用日常认知量表记忆域的患者与知情者评分差异来操作化,基线用[18F]florbetapir PET测Aβ。结果发现Aβ负荷预测记忆觉察纵向下降,且Aβ与临床分组交互,痴呆组效应最强但认知正常组也可见。认知正常进展为MCI者MCI诊断前1.6年觉察增高,随后以-0.08差异分/年下降;MCI进展为痴呆者觉察低并持续下降(-0.23差异分/年),痴呆前3.2年达病感失认。

要点

  • Aβ负荷越高,记忆觉察下降越快,痴呆组效应最强但认知正常组也可见。
  • 认知正常进展为MCI者,MCI诊断前1.6年觉察增高,随后以-0.08差异分/年下降。
  • MCI进展为痴呆者觉察低并持续下降(-0.23差异分/年),痴呆前3.2年达病感失认。

核心结论

  • Aβ负荷与记忆缺陷自我觉察的进行性下降相关,约在痴呆诊断前3年达到病感失认。

研究设计与样本

  • 纵向队列研究,纳入1070例阿尔茨海默病谱系个体,平均随访4.3次。
  • 记忆觉察用日常认知量表记忆域的患者与知情者评分差异操作化。
  • 基线用[18F]florbetapir PET测Aβ沉积。

主要发现

  • Aβ预测记忆觉察的纵向变化,Aβ负荷越高觉察下降越快。
  • Aβ与临床分组交互预测记忆觉察变化,痴呆组效应最强,认知正常组也可见。
  • 认知正常进展为MCI者,MCI诊断前1.6年觉察增高,随后以-0.08差异分/年下降至进展为MCI。
  • MCI进展为痴呆者初始觉察低并持续下降(-0.23差异分/年),痴呆前3.2年达病感失认。

临床怎么用

  • 对认知正常和MCI患者可结合Aβ负荷关注记忆觉察变化,辅助评估进展风险。
  • 记忆觉察下降可早于MCI和痴呆诊断数年出现,动态评估患者与知情者评分差异有临床价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Unawareness, or anosognosia, of memory deficits is a challenging manifestation of Alzheimer's disease (AD) that adversely affects a patient's safety and decision-making. However, there is a lack of consensus regarding the presence, as well as the evolution, of altered awareness of memory function across the preclinical and prodromal stages of AD. Here, we aimed to characterize change in awareness of memory abilities and its relationship to beta-amyloid (Aβ) burden in a large cohort (N = 1,070) of individuals across the disease spectrum. METHODS: Memory awareness was longitudinally assessed (average number of visits = 4.3) and operationalized using the discrepancy between mean participant and partner report on the Everyday Cognition scale (memory domain). Aβ deposition was measured at baseline using [18F]florbetapir positron emission tomographic imaging. RESULTS: Aβ predicted longitudinal changes in memory awareness, such that awareness decreased faster in participants with increased Aβ burden. Aβ and clinical group interacted to predict change in memory awareness, demonstrating the strongest effect in dementia participants, but could also be found in the cognitively normal (CN) participants. In a subset of CN participants who progressed to mild cognitive impairment (MCI), heightened memory awareness was observed up to 1.6 years before MCI diagnosis, with memory awareness declining until the time of progression to MCI (-0.08 discrepant-points/yr). In a subset of MCI participants who progressed to dementia, awareness was low initially and continued to decline (-0.23 discrepant-points/yr), reaching anosognosia 3.2 years before dementia onset. INTERPRETATION: Aβ burden is associated with a progressive decrease in self-awareness of memory deficits, reaching anosognosia approximately 3 years before dementia diagnosis. ANN NEUROL 2020;87:267-280.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Hanseeuw BJ, Scott MR, Sikkes SAM, et al. Evolution of anosognosia in alzheimer's disease and its relationship to amyloid. Ann Neurol. 2019. PMID: 31750553. doi:10.1002/ana.25649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。